Skip to content

The company has been backed by two North East England investors.    

Based in Newcastle-upon-Tyne, OPCI develops Machine Learning tools to support clinicians with decision making around elective surgery.  

Following a personal interest in data science, the pair have developed the platform OpenPredictor. The software uses a machine learning model, trained on anonymised patient data, to give a predicted risk score for patients due to have hip or knee replacement surgery. 

The company has plans to integrate the software in pre-operative assessment process at hospitals, with the goal of supporting the reduction of waiting times for elective surgery.

Having secured £600,000 in investment, OPCI are currently embarking on a pilot in Southwest Wales with Hywel Dda University Health Board, and Swansea Bay University Health Board. 

Justin Green, CEO and Founder, said: “During my career as an orthopaedic surgeon, I’ve identified an opportunity for the pathway from patient referral to surgery to be improved through technology. With the length of waiting lists having only increased, the need to take advantage of this technology is as acute as ever.”

“Our Machine Learning tool OpenPredictor has the potential to make a real difference by supporting doctors in their decision making ahead of patient surgery. This funding allows us to continue its development alongside the clinicians, healthcare professionals, and patients it is designed to benefit.”  

The funding has been put forward by two investors based in the north-east of England with significant experience in the medical device industry.  

Read the original story here: OPCI (Open Predictor Clinical Intelligence) secures £600K Seed Investment – UK Tech Investment News by Deal Lite